Dechra Veterinary Products, manufacturer of the leading feline hyperthyroidism treatment Felimazole®, has launched a new website for cat owners about the disorder: www.hyperthyroidcat.co.uk
The website is an online version of Dechra's popular client booklets on feline hyperthyroidism and, since its launch, has averaged 500 unique visitors a month. With pages on diagnosis, treatment and even tips on how to give a pill to a cat, owners now have a place to go for more information and advice on the disease.
Matthew Olsen, product manager at Dechra Veterinary Products says: "This website is perfect for helping owners better understand and manage hyperthyroidism in their cat. It's also useful for practices as they now have somewhere to refer owners to for more information about the diagnosis and management of this complex hormonal disease."
Cards with the new website address are available for practices to hand to clients, along with waiting room posters that will serve as a further reminder of the new site. "The website allows clients to browse the site in the comfort of their own home and is also ideal for practices with limited storage space for client information materials," Dr Olsen continues. "The posters, cards and website enhance Dechra Veterinary Products' existing range of marketing materials available to vets and owners on the subject of feline hyperthyroidism."
Dechra also encourages practices that have their own websites to link directly to http://www.hyperthyroidcat.co.uk/. Practices can order posters and hand-out cards by contacting Dechra on 01743 441632 or email: info@dechra-uk.com
The Royal College of Veterinary Surgeons has set up a new Veterinary Legislation Group to consider proposals for changes in veterinary regulation, in the light of the Environment, Food and Rural Affairs Committee's inquiry into the current Veterinary Surgeons Act, and the Government's response to the EFRA Committee's report.
The new group, which will be chaired by RCVS Council Member and Dean of Glasgow Veterinary School, Professor Stuart Reid, will be tasked with taking a fresh look at changes that need to be made to the current legislative framework, and how these might be accomplished. It will not restrict itself to looking at a replacement for the Veterinary Surgeons Act, but will consider other ways that changes can be made in the short- and long-term.
The Group will meet in September, and comprise RCVS Council members and non-members - both lay people and veterinary surgeons. Once the RCVS position has been clarified, further discussion will follow with DEFRA, the BVA and the profession.
Responding to the Government's response to the EFRA Committee report, RCVS President Jill Nute said: "We welcome the fact that DEFRA is willing to consider any detailed proposals that might come forward from the profession, although we accept that DEFRA itself does not have time or resources to be proactive at this stage.
"We are also pleased that Government acknowledges that the veterinary nursing profession has come of age and that the time is right for the regulation of veterinary nurses to be taken forward, although again it is disappointing that DEFRA does not have the resources to progress this at present.
"Finally, we welcome the suggestion that the Presidents of the BVA and the RCVS meet with the Chief Veterinary Officer to discuss plans and to what extent DEFRA can help us - accepting the fact that DEFRA, like the RCVS, feels that a piecemeal approach may not be the most effective," she concluded.
The Company of Animals has announced the launch of the CLIX® Car Safe Harness. Designed by Animal Psychologist and founder of The Company of Animals, Dr. Roger Mugford, the CLIX® Car Safe harness has been designed to maximise safety and comfort for dogs while ensuring easy fitting and use for owners.
Ergonomically designed from one continuous loop of approved, safety-standard seatbelt material, the CLIX ® Car Safe Harness provides maximum strength restraint in the unfortunate case of an accident. With a simple buckling mechanism, there is no need to fiddle around with the dog's legs to get them through the harness. Instead, the harness clips from either side of the dog and then plugs into the seat belt socket. Alternatively, it can be looped through the seat belt harness, easily adjusting to any type of car.
The CLIX ® Car Safe Harness has been lined with soft neoprene padding at all points of contact for maximum comfort and safety. Special attention has been paid to the cross design used to protect the dog's chest to ensure that the harness remains in place, even when the dog changes position.
CLIX® Car Safe Harness is available in four sizes and is suitable for most breeds of dog. It comes with a free guide on safe travelling with dogs full of helpful tips on car safety. The CLIX® Car Safe also doubles as a walking harness.
For more information, visit http://www.companyofanimals.co.uk/clix-carsafe.php
ESCCAP - the European Scientific Counsel Companion Animal Parasites - is calling for veterinary practitioners, pet owners and human health physicians to work in unison to reduce the risks associated with zoonotic transmission of parasitic diseases.
The group, comprising eminent European veterinary practitioners and leaders in veterinary parasitology and public health, have joined forces to develop independent guidelines and educational materials for the optimal control of internal and external parasites that threaten the health of pets and people.
"Our mission is simple - to ensure that parasites are no longer a health issue for pets or humans across Europe," said Maggie Fisher, ESCCAP Director, ESCCAP UK member. "Our data and research clearly outlines the future spread of certain parasites across Europe and what will happen in the UK if preventative measures are not taken seriously. The group has been formed to provide free, scientifically robust and accessible material to every interested party."
Policy guidelines to outline prevention and management strategies for endoparasites and ringworm are now readily available with guidelines on ectoparasites and vector-borne diseases in development. There is a website for veterinary professionals - http://www.esccap.org/ with a pet owner website currently in development. Practitioners also have access to important research and comparison data that shows future trends and the potential threat to the country's canine and feline population.
Maggie said: "The first policy guideline we launched is on the subject of worms. There are a wide range of worms that can infect dogs and cats not only in mainland Europe, but increasingly in the UK. Some of these worms are more important than others due to prevalence, their pathogenicity for the host and their zoonotic potential. This guideline aims to provide an overview of these worms, their significance and, importantly, suggests rational control measures for the most important species. We've looked closely at methods of preventing or controlling infection in the animal, prevention of transmission via environmental contamination to other animals and humans, and prevention of human infection. Our aim is that this guideline policy is adopted in every veterinary practice throughout Europe."
Ringworm control in dogs and cats forms the basis of the second guideline policy. "The presence of dermatophytosis is influenced by a number of factors relating to the animal, environmental issues and the crowding of animals. This guideline recommends a management programme for ringworm and what vets should be considering in the treatment, management and control of dermatophyte transmission."
Vets wishing to obtain a downloadable version of the policy papers can do so free of charge from www.esccap.org.
Practices wishing to sign up to ESCCAP for regular updates and further information should email: queries@esccap.org.uk.
ESCCAP is supported by Novartis Animal Health, Merial and Bayer HealthCare Animal Health.
Boehringer Ingelheim has released details of research presented at the 29th World Veterinary Congress which shows dogs with congestive heart failure (CHF) due to myxomatous mitral valve disease (MMVD) live longer when treated with pimobendan (Vetmedin®) compared with a commonly used ACE inhibitor.
The results of the QUEST trial, the largest international study of its kind to be conducted amongst dogs with congestive heart failure, are due to be published in the Journal of Veterinary Internal Medicine (JVIM) later this year.
The condition myxomatous mitral valve disease (MMVD) accounts for approximately 75% of all cases of CHF in dogs2. MMVD is associated with the thickening of the cusps of the mitral valve (one of the main one-way valves within the heart), affecting the flow of blood from the heart to the rest of the body. Although there is no cure for CHF due to MMVD, there are treatments available to manage the condition, improving the quality and length of the dog's life.
Professor Jens Häggström, lead investigator of the QUEST trial from the University of Uppsala, Sweden, commented that "the QUEST trial is a significant milestone in our efforts to reassure both, veterinarians and dog owners, that there is compelling evidence to show that pimobendan is an effective treatment for CHF that prolongs their dog's life and providing pet and owner with more quality time together."
The QUEST trial was a randomised, positive-controlled, multi-centre trial conducted at 28 sites across 11 countries, and is the largest study of its kind ever conducted in veterinary cardiology. The study compared a pimobendan group with a group treated with benazepril hydrochloride on top of background diuretic therapy. The trial spanned three years and followed dogs to death, euthanasia or treatment failure leading to withdrawal from the trial.
Research by Boehringer has also shown that over 50% of dog owners in the UK are unaware that their dog may be at risk of heart failure. Heart disease affects one in four dogs over seven years of age, and the lack of knowledge about this serious, life-threatening condition suggests that there is a need for better education amongst dog owners on how to recognise the disease, and how to maintain their dogs' heart health.
The RSPCA has released the latest figures showing the extent of cruelty to animals in the UK.
In 2007, they show a:
"These animals are the helpless victims of our affluent, throwaway society," says Tim Wass, Chief Officer of the RSPCA Inspectorate. "They're bought on a whim and discarded when the novelty wears off. Today's must-have item quickly turns into tomorrow's cast-off.
"Worse still," added Tim, "some animals are violently abused because they don't meet their owners' unrealistic expectations: like the cat kicked to death for having muddy paws or the dog strangled with its lead for misbehaving."
But the year RSPCA reports that there has been good news too, with the success of the new Animal Welfare Act already starting to take effect. The new Act - which came into force during 2007 - has made it possible to take action sooner than ever before in situations where there are animal welfare concerns.
The Act is already producing powerful results in its first twelve months. Where animal welfare concerns have prompted the RSPCA to give advice to an animal owner, that advice was followed and the problems resolved 92% of the time, meaning that no further action was necessary. Tim said: "Even in these early days, the benefits of the new law are clear. Without the new Act, this year's cruelty figures could have been even more horrific."
He added: "Dogs have always borne the brunt of cruelty - from violent outbursts to extreme neglect. But that's what makes this year's horrendous 34% increase even more shocking: it's a massive increase on an already high figure."
It was hoped that last year's leap in convictions for cruelty to horses was an anomaly. But this year's figures show that the higher numbers have been maintained - they increased by 33% between 2005 and 2006 - and then increased by a further 13% to 119 in 2007.
The rise in banning orders is a big improvement on the previous year, which had actually recorded a fall. The new Animal Welfare Act obliges courts to explain their reasons if they don't impose a ban and this may have contributed to the increase. The new requirement seems to have focussed attention on preventative action which can prevent suffering and save lives.
Tim said: "The main reason we take people to court is to prevent cruelty being repeated. It's very reassuring to see the courts taking this seriously by issuing more and more banning orders, which prevent those convicted of cruelty from keeping animals in future."
Lord Rooker, Minister for Sustainable Food, Farming and Animal Health has announced seven new members to the Veterinary Residues Committee (VRC).
The VRC’s role is to advise the Chief Executives of the Veterinary Medicines Directorate (VMD) and the Food Standards Agency (FSA) on the formulation of the residues surveillance programmes and on the significance of the results in terms of consumer safety.
The seven new members who have been appointed to serve on the VRC from January 2009 until December 2012 are:
The appointments were undertaken in accordance with the Code of Practice issued by the Office of the Commissioner for Public Appointments.
THE Society of Practising Veterinary Surgeons (SPVS) has published its annual Salary Survey, which provides a guide to what full time assistants are now earning.
The survey, which asked the society's members and anyone on the RCVS Register qualified for under three years to provide details about employees' salary levels, uniquely provides a breakdown of what full-time assistants are earning.
Respondents were asked to provide details of their basic salaries together with any benefits in kind such as rental accommodation, access to a car and CPD allowances, and total remuneration packages were calculated.
The survey, which is distributed along with the annual Fees Survey to SPVS members as a key benefit of membership, provides a breakdown of minimum, average and maximum salaries over categories ranging from location to the number of years qualified.
For the second year, student loan levels are featured, which, worryingly, highlights the increasing number of students graduating with large value loans.
Richard Hillman, SPVS President, said: "I very much welcome the publication of this important annual survey, which comes at a time when vet salaries and the fees we charge are under fire. It is interesting to note that the recent ‘league table' which effectively labeled us the ‘fat cats' among small businesses was based on the minority of corporate practices."
He added: "Our survey provides a very valuable base for employers to develop a transparent pay scheme and for employees to negotiate. It is particularly useful with new legislation on greater transparency of pay scales in businesses and the outlawing of salary ‘secrecy clauses' together with the Government's push for equality in male/female pay awards."
The SPVS annual Fees Survey, which provides a breakdown of fees charged across the small animal, cattle and equine sectors, will be published in September.
SPVS is run by practitioners for practitioners and if you'd like further information on the courses and membership benefits that SPVS offers, please contact the secretariat on 01926 410454 or visit the web site at www.spvs.org.uk
Hill's Pet Nutrition is offering a 100 per cent money-back guarantee that new Hill's Prescription DietTM Canine r/dTM will help overweight and obese dogs to lose weight in just 8 weeks while still maintaining lean muscle mass.
Libby Sheridan, Veterinary Affairs Manager at Hill's Pet Nutrition said: "We understand that there is a considerable amount of effort required from owners to help their pet lose weight. Along with the additional cost this can make it difficult to convince them to buy in to a prescription weight loss diet. In order to give vets and pet owners confidence, Hill's is offering a 100 per cent money-back guarantee to pet owners if they don't see any weight loss in just eight weeks."
New r/d, available in 1.5kg, 4kg and 12kg bags, helps with the nutritional management of overweight or obese dogs. According to Hill's, palatability has increased with 9 out of 10 dogs preferring new r/d and its high fibre formula also provides dietary bulk to aid satiety and avoid hunger. New r/d also has high levels of L-carnitine to help burn fat while maintaining lean muscle mass.
Hill's has developed a range of support measures and practice display materials to help raise awareness of obesity and encourage pet owners to try new r/d. For further information please contact your Hill's Territory Manager or call 0800 282438.
Merial Animal Health, makers of Previcox® have launched a new technical manual containing expert thinking on canine osteoarthritis (OA) and other orthopaedic subjects.
Recipients will also have the opportunity to test themselves and their colleagues on the technical content for their chance to win £500 worth of CPD vouchers.
Previcox product manager Claire Parry-Baggott said: "We have been very fortunate in being able to work with some of the UK's most highly regarded experts in the field of OA.
"The first issue just released contains two papers, the first from Gareth Clayton-Jones, BVetMed DVR DSAO HonFRCVS, RVC specialist in both small animal othopaedics and diagnostic imaging. Mr Jones discusses anterior cruciate ligament rupture, including examination, radiography and treatment options.
"The second paper in this first edition is from specialist in small animal orthopaedics Prof. John Innes BVSc PhD CertVR DSAS(orth) MRCVS, of the University of Liverpool, who looks at elbow dysplasia. In his paper Professor Innes provides a detailed but practical guide to the condition."
Additionally to support Gareth Clayton-Jones' first issue there is a DVD highlighting common clinical presentations of dogs suffering from stifle disease.
Claire said: "With two papers in this first issue there's a total of £1,000 of CPD vouchers up for grabs."
"Each paper has a related quiz containing key questions from the discussion. The winner will be the first correct entry drawn at random," she explains. "Other topics to be covered in the series include Osteochondritis Dissecans (OCD); pain and analgesics; rehabilitation; hips; and spines.
"The manual is set to provide a comprehensive, up-to-date practical guide to OA and related conditions. Subsequent papers will be issued on a quarterly basis and will also contain a quiz sheet with the opportunity to win £500 of CPD vouchers," concludes Claire.
If you haven't already received your copy, contact your local Merial territory manager or call the customer hotline on 0870 6000 123.
CEVA Animal Health has confirmed its sponsorship of Stephanie Dakin, an equine veterinary PhD student at the Royal Veterinary College in London.
The four-year sponsorship, due to commence October 2008, is being run through the BBSRC Industrial CASE studentship scheme, which involves partnerships between UK-based industrial companies and eligible UK universities or research institutes, to support collaborative postgraduate research. It is the first time that CEVA, the company that recently introduced Tildren®, a treatment for equine bone disease, has undertaken such an initiative in the UK.
Stephanie is conducting her PhD on the pathogenesis and treatment of equine tendonitis. She is currently working with Professor Roger Smith, Professor of Equine Orthopaedics and Dr Jay Dudhia at the RVC, on a study to determine the efficacy of stem cells in the treatment of superficial digital flexor tendonitis in the horse.
Stephanie commented: "I am very keen to direct research in this field in order to better elucidate the mechanisms involved in tendon injury and identify therapeutic targets, such that we can improve our management and hopefully advance our ability to treat and prevent disease, thus improving the health and welfare of equine patients."
She added: "Having the opportunity to undertake this vital research, supported by the BBSRC and the industrial contribution from CEVA, is a real privilege and I hope that the findings from this study will feedback to have a direct, positive impact on clinical cases of tendonitis, in the equine and possibly the human fields."
A new scholarship on Equine Emergency and Critical Care has been started at a specialist equine hospital in County Kildare, at the heart of Ireland’s horse-racing district. Anna Hollis is the recipient of the scholarship, which is the first of its kind in Europe.
The scholarship gives her the opportunity to specialize in the field of emergency and critical care and to be Board Certified by the American College of Veterinary Emergency and Critical Care (ACVECC). The scholarship has been funded by a grant from Intervet/Schering-Plough Animal Health.
Anna Hollis (BVet Med, MRCVS) will receive the scholarship, for a duration of two years. Hollis just completed a residency in Medicine at the University of Pennsylvania (New Bolton Center) and already has several publications. She will be under the supervision of Kevin Corley (BVM&S PhD DECEIM DACVIM DACVECC MRCVS), an expert in the field of equine medicine and Board Certified by the ACVECC who is in charge of emergency and critical care at a large equine hospital in the Curragh area of County Kildare, Ireland.
Anna Hollis will be spending several rotation periods in various institutions in Europe and the USA, before taking the board examination for the ACVECC. This is the only equine Emergency and Critical Care residency in the European Union that is recognized by the ACVECC and one of the few in the world taking place at a private institution.
Intervet/Schering-Plough Animal Health is supporting this two-year initiative, “We are very excited to be working with Dr. Corley to establish this scholarship,” said Roberto Ragni-Alunni, Global Technical Manager for the equine business in Intervet/Schering-Plough Animal Health. ”The research offers the possibility to reach a rare level of specialization. This will benefit critically ill horses and help push the boundaries of equine medicine even further.”
Woodley Equipment has expanded its support team with the appointment of Greg Woloszczuk as the new Wet Chemistry Product Support Specialist.
Greg joins Woodley from the veterinary industry where he worked for 5 ½ years as a Service Manager. He will focus on all areas of customer service, pre and post sales, along with organising servicing, repairs and maintenance of the Woodley wet chemistry analysers.
Dechra Veterinary Products has announced the appointment of Bob Parmenter as managing director of its UK business.
Commenting on his appointment, Bob said: "I'm pleased to have joined Dechra at a very exciting stage of the company's development. I've been following the growth of Dechra over recent years and with its acquisition of VetXX in January, I believe that the business is now strongly placed to further establish itself as a leading player in the animal health industry."
Having spent nearly 40 years in the industry, Bob Parmenter has previously worked for Schering-Plough, Mallinckrodt Veterinary, Pitman-Moore, Coopers Animal Health and ICI Pharmaceuticals. "My career path has enabled me to experience all aspects of the animal health market. I'm confident my industry-wide knowledge will provide Dechra with additional experience as we continue to build our reputation and strengthen our UK market position."
Former MD Giles Coley, who joined Dechra in 1999 and has managed the UK business since 2003, has been promoted to European Pharmaceutical and Export Sales Director. As a member of Dechra Veterinary Product's European Board he will be responsible for co-ordinating pharmaceutical sales across Europe and developing the company's export sales.
This is the call to Government from an industry-wide stakeholder group that has joined forces and vowed to do everything in its power to stamp out the disease which is seeing upwards of 28,000 cattle a year culled.
The industry stakeholder group has put its name to an eight-point statement of agreement following the non-decision announced by the Secretary of State, Hilary Benn, on dealing with bTB.
Included in the eight points is a call for an independent body to take on the future decision making for animal health; a commitment of non-participation in the TB Partnership Group as announced by the Secretary of State; and an industry policy of non-participation in discussions on cost sharing and responsibility on animal health and welfare issues.
The NFU, which hosted the stakeholder meeting, has been heartened by a report, also out today, from the Efra select committee on badgers and cattle TB which says the Government is playing down the serious nature of bovine TB. In its response the committee, chaired by the Rt Hon Michael Jack MP, says:
NFU Deputy President Meurig Raymond said: “The industry feels let down and angered by the Government’s abdication of responsibility around this devastating disease. We have been left with no choice but to walk away from any attempt by Government to validate their ‘policy’ decision and pass responsibility for controlling this disease to the already beleaguered cattle sector. The Efra committee’s report reinforces both the fact that the Government has made the wrong decision and the need for something to be done now rather than waiting for vaccines to become available years down the line which will be too late for many farmers whose businesses are being decimated by this disease. The Efra report recognises the value of the VLA9 culling proposal put together by the NFU and other industry bodies for the South West of England. Hilary Benn has been invited to meet the people involved with VLA9 but has declined to do so which, given the hard work that has been put in on the plan, is very disappointing.”
Lohmann Animal Health has launched AviPro IBD Xtreme vaccine against Infectious Bursal Disease — also known as Gumboro Disease — in broilers, commercial layers and breeders.
According to Lohmannn, it is highly effective against the vvIBDV (very virulent IBD virus), it breaks through high levels of maternal antibodies, and controls mortality with no loss of flock performance.
Since the 1980s the acute form of IBD has caused significant economic loss to the poultry industries in several countries. The vvIBDV, a more aggressive form first described in Europe in 1986, is now widespread throughout the world and can cause losses of 30-60 per cent in layers and 5-25 per cent in broilers.
Chicks are most susceptible between one and six weeks. Early in their lives they are protected by maternally-derived antibodies (MDAs), but these antibodies will neutralise live IBD vaccines when they are given too early. However, being highly invasive, the AviPro IBD Xtreme vaccine is able to overcome these MDAs so can be given earlier to provide greater protection from an early age.
Exact timing of vaccination depends primarily on the level of MDAs and the breakthrough titre of the vaccine on the one hand, and the virulence of the field virus and infection pressure on the other.
When compared with four of its main competitors in a trial with SPF birds AviPro IBD Xtreme outperformed them. It had the highest number of sero-positive birds, the highest mean ELISA-antibody titre seven days after vaccination and the best protection against clinical symptoms and mortality after a challenge with vvIBDV,” commented Brigitte Othmar, regulatory affairs manager at LAH.
“With the addition of AviPro IBD Xtreme, Lohmann Animal Health has now completed its range of live IBD vaccines and is able to provide its customers with the appropriate solution for any Gumboro problem,” she added.
AviPro IBD Xtreme can be applied via the drinking water or eye-drop and is presented in vials of 1,000 and 2,500 doses.
More information on this vaccine can be found on the Lohmann Animal Health website http://www.lah.de/.
The latest addition to the Tracer® Advance microchip practice support package is a free story book, designed specifically to entertain and educate children in the waiting room, but also to serve as a timely reminder to pet owners of the need to have their pets chipped.
Despite the improved awareness of the benefits of microchipping and year-on-year increases in the numbers of pets being chipped, around 70% of cats and dogs remain unchipped.
Practices can order copies of Lily and the Magic Microchip from their Bayer Animal Health representative. Additional sales support material with an educational theme will be made available later in the year, particularly as the annual fireworks campaign approaches. Tracer Advance is the only polymer microchip available in the UK and is only available through veterinary practices.
Three new learning aids launched by BVA:
Practical Animal Handling - Online Tutorial The BVA AWF have launched an online tutorial on practical animal handling which has been prepared in conjunction with Newcastle University. The tutorial is primarily aimed at veterinary students and nurses. It features videos of expert veterinary staff demonstrating the correct procedures for handling small animals for clinical examination and medication and its aim is to show that the primary consideration should be for the welfare of the animal. To access the online tutorial visit http://www.bva-awf.org.uk/resources/tutorials/.
Disbudding of Kid Goats The Goat Veterinary Society (GVS) has produced a DVD designed to help veterinary surgeons to disbud goats. Produced in association with the BVA Animal Welfare Foundation the DVD is in memory of the late Mike Teale MRCVS, following a donation from his family. The DVD discusses the potential problems associated with disbudding kid goats and provides guidance on how to avoid them. It shows the best technique for disbudding from start to finish and discusses anatomical considerations, methods of anaesthesia and analgesia and disbudding, with particular attention drawn to the regulatory aspects as they currently apply in the UK. For further information on the GVS DVD, including obtaining a copy, at a cost of £10, please visit http://www.bva-awf.org.uk/headlines/news/Disbudding_of_kid_goats_DVD__2_.pdf.
Bat Care Guidelines - a Guide to Bat Care for RehabilitatorsThe Bat Conservation Trust (BCT) has produced Bat Care Guidelines, in association with the BVA AWF, RSPCA and RCVS Trust, aimed at veterinary professionals, wildlife hospitals and new rehabilitators. The document is split into basic sections including 'health and safety', 'rescue and collection' and 'ailments and treatments' which aim to provide minimum guidelines for bat care. The new initiative is part of an ongoing partnership focusing on the rehabilitation of wild bats in the UK. Visit http://www.bva-awf.org.uk/grants/projects/BCT_workshop_article_08.pdf for further information
Fort Dodge has unveiled an initiative to help practices improve peri-operative care and the management of hospitalised cases with the launch of its Early Warning Scoring System (EWSS) kit.
The kit contains cat and dog anaesthesia and observation charts for the effective monitoring of cats and dogs during operations, post-operatively and for hospitalised medical cases.
EWSS observation charts are widely used in the NHS but this is believed to be the first time that such a system has been developed specifically for use in veterinary practices.
They have been designed by Mike Davies BVetMed CertVR CertSAO FRCVS, Technical Services Manager at Fort Dodge, and are intended to help veterinary nurses and veterinary surgeons identify patients whose condition is deteriorating before they reach a critical state.
Mike Davies speaks around the country on preventive medicine and geriatrics and his experience of working closely with practices is that many do not have good protocols in place for nurse monitoring of patients. The EWSS grades parameters such as heart rate, respiratory rate, blood pressure and CNS response and the charts incorporate areas in which the practice can record pain using a visual analogue scale or a numeric scoring system.
The company has also launched Dorbene vet, a new product providing fast-acting sedation and analgesia for dogs and cats. Its active ingredient is the trusted and well proven alpha-2 agonist medetomidine hydrochloride, which affects the nervous system by inhibiting noradrenaline mediated neurotransmission. A dosing guide for Dorbene vet is also included in the EWSS.
The launch of Dorbene vet complements Fort Dodge's existing companion animal products, analgesic Torbugesic and dissociative anaesthetic Ketaset. Used alone it offers dose-related sedation within 10-15 minutes, which is rapidly reversible using the alpha-2 antagonist atipamezole for predictable recovery. It is presented in 10 ml and 50 ml multi dose vials in amber coloured glass which protects the product from light.
For further information on the EWSS or Dorbene vet, contact Fort Dodge on 01489 781711.
The story of ‘Spliff' the Staffy has clinched the title of the National Office of Animal Health nationwide search for the most striking ‘it shouldn't happen to a pet' anecdote. Submitted by Vets4Pets in Grimsby, the practice will receive a prize of £500 towards the staff Christmas party.
In a campaign to raise awareness of the importance of animal health and welfare considerations amongst pet owners and potential owners, NOAH has recently launched the new Pet Health Information website (www.pethealthinfo.org.uk) to enable them to make informed decisions about their pet's healthcare.
In Spliff's case, the website could have helped solve a number of queries. For Spliff it all started with a visit to the vet for a minor operation to cure a simple earache.
The problems started as Spliff was about to leave the practice, with a shiny new bucket collar. However, his owner explained that Spliff is a bit of a snappy dresser, and if it isn't bling, he's not interested. Despite the practice's advice, he insisted the collar was removed so he could take Spliff home to recover.
The very next day, the phone started ringing ‘Spliff's scratching his ear - we need a collar.' Far too busy to bring him round, the owner sent his girlfriend to pick it up.
Problem solved - surely? Nope. The phone continued to ring. Spliff was ‘going nuts!' Apparently the dog was unable to walk, and was getting very distressed.
Finally, after nearly 24 hours of increasingly frantic calls, Spliff's owner brought him in. He arrived insisting that the vet came out to the car, as Spliff still couldn't walk. Not a common side effect of a minor operation on the ear, so it was a worry.
All became very clear when the vet reached the car, the ear was healing up nicely, and Spliff's paralysis was easily solved. They had put his bucket collar on the wrong way round, and every time he took a step - his front feet got trapped in the collar.
Rather than collapse in a heap, Spliff, in one of the first sensible decisions of his life, chose not to move at all. Mystery duly solved, Spliff went on to make a full recovery.
Sounds like the owner should probably smoke a bit less of it.
The RCVS has launched a research project into the extent to which veterinary surgeons are able to meet its requirement that steps are taken to provide 24-hour emergency cover.
The College's 24-hour Emergency Cover Working Party (24-7 WP) has been considering the ongoing practicality of the current requirement in the Guide to Professional Conduct, and whether it should remain, be removed, or be amended in some way. The research aims to build a sound evidence base on which a decision can be made.
"Changes in practice profiles and owner demands, health and safety issues, the desire for an improved work-life balance, veterinary and animal density... all these factors affect the ability of veterinary practitioners to meet our 24-7 requirement. The Working Time Regulations - which prescribe maximum working hours and minimum rest periods - have also affected practices' ability to run out-of-hours services," according to RCVS President Jill Nute.
"However, we are frequently reminded by members that the profession is proud to offer a 24-hour emergency service to animals and their owners. There seems to be no single majority view in the profession, so we need to understand exactly how people are meeting the requirement before any changes are made," she says.
To ensure that the research is independent and representative, the RCVS has contracted a specialist market research agency, Cognition Market Intelligence.
The first step is to build a robust and unbiased questionnaire that takes account of all of the issues. To this end, in-depth interviews will be carried out over summer with a small number of veterinary surgeons from a range of different practice types, and across different gender/age/role categories.
The 24-7 WP will then meet in September to hear the findings and agree the questionnaire, which Cognition Marketing Intelligence will then use during autumn as part of a quantitative phone interview exercise with 440 veterinary surgeons, again covering a spread of individuals, practice types and geographies. The phone interview approach will ensure that the views of a range of different practitioners are heard, which is not always the case with a paper survey.
Should changes to the Guide to Professional Conduct be recommended by the Working Party on the basis of the findings, a consultation exercise may be undertaken.
The RCVS President has sent a letter to all home-practising members to explain the activities. She has urged veterinary surgeons to assist the research team, saying "your contribution will make a difference".
Research on ovine parasite Toxoplasma gondii, carried out at the University of Salford, could have a significant economic impact on the sheep farming industry - potentially saving the lives of 5% of the UK lamb population.
Postgraduate student Emma Morley has been working as part of a large research team, looking at the importance of transmission routes of T. gondii (the cause of the disease toxoplasmosis) within different mammalian groups.
A scholarship from the Perry Foundation, which funds research benefiting the farming industry, allowed Emma to launch her own study at the School of Environment & Life Sciences.
Salford parasitologist Professor Geoff Hide said: "Emma's research may have some significant impacts on sheep farming. Nearly 5% of lambs are lost to Toxoplasma in the UK so it's of major economic importance as well as an important animal welfare issue."
He said that one of the key things Emma's research has shown is that the advice currently given to farmers may be causing an increase in the level of the disease rather than controlling it. "Farmers are advised to breed from ewes that have lost lambs to Toxoplasma but Emma's results show that what farmers should be doing is breeding from ewes that do not have the parasite," he said.
Britain's leading equestrian organisations are conducting a survey to find out more about the welfare standards in livery yards. Livery yards are very popular in the UK for those people who are unable to keep their horses and ponies at home. However, there is no record of how many horses are currently at livery or indeed the number of operating yards and the welfare standards under which they operate. Representatives from the British Equine Veterinary Association (BEVA), World Horse Welfare, The British Horse Society, RSPCA, Association of British Riding Schools, South Essex Insurance Brokers (who currently insure a total of 8,562 DIY and livery stables), and for local government LACORS and CIEH, set up a working party to carry out some research into UK livery yards to become better informed about standards. The group took the view that asking vets and the public about their local livery yard would help to obtain information about the number of yards and get a general picture of the range and standard of accommodation and services that livery yards offer. Veterinary surgeons, horse owners, grooms, yard owners, farriers and other equine professionals are invited to complete the online survey at http://www.liveryyardsurvey.co.uk/. Please complete a survey for each livery yard about which you have first hand knowledge. Your answers will remain confidential, and the results will be reviewed in September 2008 to establish what further action, if any, is necessary.
Defra has announced that the Bluetongue Protection Zone will be extended again on Monday 21 July, following the delivery by Intervet of almost 2 million additional doses of Bluetongue serotype 8 (BTV-8) vaccine. Vaccination is only permitted within the Protection Zone. In accordance with the Bluetongue vaccination plan, the Protection Zone will be extended to cover Worcestershire and the districts in North Yorkshire (Scarborough, Ryedale, Hambleton & Harrogate), Cheshire (Macclesfield, Congleton & Crewe and Nantwich) and Greater Manchester (Rochdale, Oldham, Tameside and Stockport) previously in the Surveillance Zone. Defra will continue to roll out vaccination as vaccine is delivered, in line with the vaccination roll-out plan. The additional vaccine is available for use in the existing Protection Zone from today. Livestock keepers in the areas coming into the Protection Zone will be able to obtain the vaccine from Monday. However, they are encouraged to order vaccine so that they can protect their livestock at the earliest opportunity. Protection Zone restrictions will apply to those keepers coming into the extended zone. Animals can only be moved out of the Protection Zone if they are vaccinated, naturally immune or moving for slaughter, subject to meeting certain conditions. Please refer to the Defra website for further guidance. Defra also confirmed that the Merial BTV-8 vaccine has been awarded a provisional marketing authorisation from the Veterinary Medicines Directorate. The granting of a provisional marketing authorisation is an important step in confirming that the vaccine will be safe and effective. On 11 June, Defra placed an order with Merial to deliver 13 million doses of BTV-8 vaccine, eight million for use in England and five million for use in Wales.